Development of a Luminex-Based DIVA Assay for Serological Detection of African Horse Sickness Virus in Horses
- 19 April 2016
- journal article
- research article
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 63 (4) , 353-359
Abstract
African horse sickness (AHS) is considered a fatal re-emergent vector-borne disease of horses. In the absence of any effective treatment for AHS, vaccination remains the most effective form of disease control. The new generation of vaccines, such as one based on purified, inactivated AHS virus (AHSV, serotype 4), which does not induce antibodies against non-structural protein 3 (NS3), enables the development of diagnostic methods that differentiate infected from vaccinated animals (DIVA assays). As detecting AHS in AHSV-free countries may lead to restrictions on international animal movements and thereby cause significant economic damage, these DIVA assays are crucial for reducing movement restrictions. In this article, we describe a Luminex-based multiplex assay for DIVA diagnosis of AHS, and we validate it in a duplex format to detect antibodies against structural protein 7 (VP7) and NS3 in serum samples from horses vaccinated with inactivated AHSV4 vaccine or infected with a live virus of the same serotype. Results of the Luminex-based assay for detecting anti-NS3 antibodies showed good positive correlation with results from an in-house enzyme-linked immunosorbent assay (ELISA). Thus, the Luminex-based technique described here may allow multiplex DIVA antibody detection in a single sample in less than 2 h, and it may prove adaptable for the development of robust, multiplex serological assays.Keywords
Funding Information
- Seventh Framework Programme (FP7-KBBE-2011-5)
This publication has 17 references indexed in Scilit:
- Expression of the major epitope regions of 2C integrated with the 3AB non-structural protein of foot-and-mouth disease virus and its potential for differentiating infected from vaccinated animalsJournal of Virological Methods, 2010
- In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6Vaccine, 2010
- Re-emergence of bluetongue, African horse sickness, and other Orbivirus diseasesVeterinary Research, 2010
- Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virusVaccine, 2009
- Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse seraJournal of Virological Methods, 2005
- African horse sicknessVeterinary Research, 2004
- THE non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattleArchives of Virology, 1997
- The use of African horse sickness virus NS3 protein, expressed in bacteria, as a marker to differentiate infected from vaccinated horsesVirus Research, 1995
- Characterization of African horsesickness virus serotype 4-induced polypeptides in Vero cells and their reactivity in Western immunoblottingJournal of General Virology, 1993
- A competitive ELISA for the detection of group-specific antibodies to African horse sickness virusEpidemiology and Infection, 1990